Literature DB >> 29384526

Reply to 'Comment on 'Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system".

Jeong Mo Bae1,2, Jung Ho Kim1,3, Yoonjin Kwak3,4, Dae-Won Lee5, Yongjun Cha5, Xianyu Wen1, Tae Hun Lee1, Nam-Yun Cho1, Seung-Yong Jeong6, Kyu Joo Park6, Sae Won Han5, Hye Seung Lee3,4, Tae-You Kim5, Gyeong Hoon Kang1,3.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 29384526      PMCID: PMC5808037          DOI: 10.1038/bjc.2017.426

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


× No keyword cloud information.
Sir, We thank Tapial for their interest in our recent study. The authors applied our revised CIMP classification to their three different clinical data sets, which are composed of patients with early-onset colorectal cancer (EOCRC) (younger than 45 years), patients with late-onset CRC (LOCRC) (older than 70 years), and individuals diagnosed with synchronous CRC (SCRC). They addressed that only LOCRC cases showed similar tendency of increasing BRAF mutation, MSI-high and MLH1 methylation along with the increase in the number of methylated genes. Moreover, they insisted that prognostic results were only partially confirmed in SCRC. Non-linearity of molecular alterations including BRAF mutation, MSI-high and MLH1 methylation in EOCRC and SCRC might originate from two reasons. First, EOCRC and SCRC have strong germline predispositions to CRC, even though they are not either familial adenomatous polyposis or Lynch syndrome (Cybulski ; de Voer ). Recent studies revealed that germline predisposition in EOCRC is greater than expected (Pearlman ); these germline predispositions are mainly associated with chromosomal instability rather than CIMP (Chan ; McGivern ). Second, CIMP-P2 CRCs usually occur in elderly patients. Two recent studies showed similar tendency in CRCs with BRAF mutation and concurrent MSI or MLH1 methylation (Seppala ; Vedeld ). The authors tried to validate prognostic value of our revised CIMP classification in their EOCRC, LOCRC and SCRC subgroups. However, considering their previous publication, the sample size of each subgroup is too small to get enough statistical power for the subgroup of low prevalence, such as CIMP-P1 and CIMP-P2 (Ogino ; Perea ; Arriba ). Considering the low prevalence of EOCRC and SCRC, a multi-centre study might be necessary to validate the prognostic value of our revised CIMP classification. Overall, Tapial et al’s results emphasise the fact that EOCRC and SCRC have different molecular landscapes compared with sporadic CRCs. Further comprehensive study might shed light on the complex interaction between germline predisposition, accumulation of somatic mutation and epigenetic alteration.
  10 in total

Review 1.  Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field.

Authors:  Shuji Ogino; Andrew T Chan; Charles S Fuchs; Edward Giovannucci
Journal:  Gut       Date:  2010-10-29       Impact factor: 23.059

2.  Toward a Molecular Classification of Synchronous Colorectal Cancer: Clinical and Molecular Characterization.

Authors:  María Arriba; Ricardo Sánchez; Daniel Rueda; Laura Gómez; Juan L García; Yolanda Rodríguez; José Antonio Pajares; Jessica Pérez; Miguel Urioste; Rogelio González Sarmiento; José Perea
Journal:  Clin Colorectal Cancer       Date:  2016-08-09       Impact factor: 4.481

3.  Early-onset colorectal cancer with stable microsatellite DNA and near-diploid chromosomes.

Authors:  T L Chan; L C Curtis; S Y Leung; S M Farrington; J W Ho; A S Chan; P W Lam; C W Tse; M G Dunlop; A H Wyllie; S T Yuen
Journal:  Oncogene       Date:  2001-08-09       Impact factor: 9.867

4.  Classifying early-onset colorectal cancer according to tumor location: new potential subcategories to explore.

Authors:  José Perea; Juana M Cano; Daniel Rueda; Juan L García; Lucía Inglada; Irene Osorio; María Arriba; Jessica Pérez; Miriam Gaspar; Tamara Fernández-Miguel; Yolanda Rodríguez; Javier Benítez; Rogelio González-Sarmiento; Miguel Urioste
Journal:  Am J Cancer Res       Date:  2015-06-15       Impact factor: 6.166

5.  Promoter hypermethylation frequency and BRAF mutations distinguish hereditary non-polyposis colon cancer from sporadic MSI-H colon cancer.

Authors:  A McGivern; C V A Wynter; V L J Whitehall; T Kambara; K J Spring; M D Walsh; M A Barker; S Arnold; L A Simms; B A Leggett; J Young; J R Jass
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

Review 6.  Multiple primary cancers as a guide to heritability.

Authors:  Cezary Cybulski; Safia Nazarali; Steven A Narod
Journal:  Int J Cancer       Date:  2014-06-19       Impact factor: 7.396

7.  Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer.

Authors:  Rachel Pearlman; Wendy L Frankel; Benjamin Swanson; Weiqiang Zhao; Ahmet Yilmaz; Kristin Miller; Jason Bacher; Christopher Bigley; Lori Nelsen; Paul J Goodfellow; Richard M Goldberg; Electra Paskett; Peter G Shields; Jo L Freudenheim; Peter P Stanich; Ilene Lattimer; Mark Arnold; Sandya Liyanarachchi; Matthew Kalady; Brandie Heald; Carla Greenwood; Ian Paquette; Marla Prues; David J Draper; Carolyn Lindeman; J Philip Kuebler; Kelly Reynolds; Joanna M Brell; Amy A Shaper; Sameer Mahesh; Nicole Buie; Kisa Weeman; Kristin Shine; Mitchell Haut; Joan Edwards; Shyamal Bastola; Karen Wickham; Karamjit S Khanduja; Rosemary Zacks; Colin C Pritchard; Brian H Shirts; Angela Jacobson; Brian Allen; Albert de la Chapelle; Heather Hampel
Journal:  JAMA Oncol       Date:  2017-04-01       Impact factor: 31.777

8.  Combination of microsatellite instability and BRAF mutation status for subtyping colorectal cancer.

Authors:  T T Seppälä; J P Böhm; M Friman; L Lahtinen; V M J Väyrynen; T K E Liipo; A P Ristimäki; M V J Kairaluoma; I H Kellokumpu; T H I Kuopio; J-P Mecklin
Journal:  Br J Cancer       Date:  2015-05-14       Impact factor: 7.640

9.  Identification of Novel Candidate Genes for Early-Onset Colorectal Cancer Susceptibility.

Authors:  Richarda M de Voer; Marc-Manuel Hahn; Robbert D A Weren; Arjen R Mensenkamp; Christian Gilissen; Wendy A van Zelst-Stams; Liesbeth Spruijt; C Marleen Kets; Junxiao Zhang; Hanka Venselaar; Lilian Vreede; Nil Schubert; Marloes Tychon; Ronny Derks; Hans K Schackert; Ad Geurts van Kessel; Nicoline Hoogerbrugge; Marjolijn J L Ligtenberg; Roland P Kuiper
Journal:  PLoS Genet       Date:  2016-02-22       Impact factor: 5.917

10.  CpG island methylator phenotype identifies high risk patients among microsatellite stable BRAF mutated colorectal cancers.

Authors:  Hege Marie Vedeld; Marianne Merok; Marine Jeanmougin; Stine A Danielsen; Hilde Honne; Gro Kummeneje Presthus; Aud Svindland; Ole H Sjo; Merete Hektoen; Mette Eknaes; Arild Nesbakken; Ragnhild A Lothe; Guro E Lind
Journal:  Int J Cancer       Date:  2017-06-02       Impact factor: 7.396

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.